Hydrogen inhalation therapy for head and neck cancer patients
Phase 2
- Conditions
- Health Condition 1: C760- Malignant neoplasm of head, face and neck
- Registration Number
- CTRI/2023/03/051034
- Lead Sponsor
- Harshamitra superspeciality cancer center and research institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.All patients with primary head and neck cancer treated with concurrent chemo radiation between February 2023 to February 2024
2.Patients belonging to all age groups, both male and females were included
Exclusion Criteria
1. Patients with Stage IV disease
2.Patients receiving palliative radiation
3.Patients with recurrent head and neck cancers on re radiation
4.Immune compromised patients and those with auto immune diseases.
5.Patients with any other disease or condition that may add to the toxicity
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method